Tanuk Pharma (India) Limited - Company Profile

It is a pharma public limited company based in New Delhi, Delhi, India, established in 1995.
1995 New Delhi, Delhi, India Active
Last Updated:
Access Report
About Tanuk Pharma (India) Limited

Tanuk Pharma (India) Limited, a active public limited company, was established on 28 February 1995 in New Delhi, Delhi, India. Engaging in pharmaceutical retailers & distributors within the pharma sector, it holds CIN: U74899DL1995PLC065899. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹8.50 Cr and a paid-up capital of ₹3.67 Cr.

It upholds a compliant status. Its leadership includes Lokesh Kumar Saxena (Additional Director), Pankaj Kumar Thakur (Director), Kidar Nath Bhalla (Director). Past directors included Anuradha Bhalla, Pankaj Kumar Thakur, Pankaj Kumar Jha. It holds ₹1.05 Cr open charges and ₹6.00 Cr settled loans. Its latest AGM occurred on 25 September 2023, with the balance sheet filed on 31 March 2023. It is based at A-11 Kailash Apartments Lala Lajpatrai Marg, New Delhi, Delhi, 110048.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U74899DL1995PLC065899

  • Registration Number

    065899

  • Incorporation Date

    28 February 1995

  • Authorized Capital

    ₹8.50 Cr

  • Paid-Up Capital

    ₹3.67 Cr

  • ROC Code

    Roc Delhi

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 8.50 Cr
  • Paid Up Capital ₹ 3.67 Cr
  • Company Age 31 Year, 10 Days
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 1.05 Cr
  • Satisfied Charges ₹ 6.00 Cr
  • Revenue Growth **** 4.91%
  • Profit Growth **** 99.62%
  • Ebitda **** 99.46%
  • Net Worth -0.00%
  • Total Assets -0.32%
Company report

Tanuk Pharma (India) Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Tanuk Pharma (India) Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Tanuk Pharma (India) Limited?
Current Directors
Name Designation Appointment Date Status
Lokesh Kumar Saxena Additional Director 23 Nov 2023 Current
Pankaj Kumar Thakur Director 10 Aug 2016 Current
Kidar Nath Bhalla Director 02 Feb 2015 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 28 Nov 2023 Past
Pramod Abcsdd Additional Director 30 Sep 2016 Past
Pramod Abcsdd Director 02 Feb 2015 Past
Pramod Abcsdd Additional Director 30 Sep 2015 Past
Pramod Abcsdd Director 28 Nov 2023 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Tanuk Pharma (India).

Tanuk Pharma (India) Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.91% increase. The company also saw a substantial improvement in profitability, with a 99.62% increase in profit. The company's net worth witnessed no change by increase of -0%.

Tanuk Pharma (India) revenue growth over time
Tanuk Pharma (India) profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 4.91%
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
 -0.32%
*******
*******
*******
*******
Profit or Loss
*******
 99.62%
*******
*******
*******
*******
Net Worth
*******
 -0.00%
*******
*******
*******
*******
EBITDA
*******
 99.46%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Tanuk Pharma (India)?

In 2023, Tanuk Pharma (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹10,450,000.00

Satisfied Charges

₹60,000,000.00

Charges Breakdown by Lending Institutions
  • Housing Development Finance Corporation Limited : 0.70 Cr
  • Standard Chartered Bank : 0.35 Cr
Latest Charge Details
Date Lender Amount Status
31 Mar 2015 Housing Development Finance Corporation Limited ₹7.00 M Open
19 Sep 2011 Standard Chartered Bank ₹3.45 M Open
16 May 2014 Bank Of Baroda ₹3.25 Cr Satisfied
10 Feb 1997 Punjab National Bank ₹2.75 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Tanuk Pharma (India)?

Unlock and access historical data on people associated with Tanuk Pharma (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Tanuk Pharma (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Tanuk Pharma (India)'s trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Tanuk Pharma (India)
Recent Activity within the Organization
  • Director Appointment

    The activity Lokesh Kumar Saxena was appointed as a Additional Director was appointed as a Additional Director on 23 Nov 2023 & has been associated with this company since 2 years 3 months . was completed.

  • Annual General Meeting

    The activity Tanuk Pharma (India) Limited last Annual general meeting of members was held on 25 Sep 2023 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Tanuk Pharma (India) Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Delhi. was documented.

  • Director Appointment

    Progress on Pankaj Kumar Thakur was appointed as a Director was appointed as a Director on 10 Aug 2016 & has been associated with this company since 9 years 6 months . was documented.

  • Charges

    A charge registered on 16 May 2014 via Charge ID 10500350 with Bank Of Baroda was fully satisfied on 22 Jan 2016. was recorded as a recent event.

  • Charges

    A charge with Housing Development Finance Corporation Limited amounted to Rs. 0.70 Cr with Charge ID 10560192 was registered on 31 Mar 2015. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Tanuk Pharma (India) Limited?

The CIN of Tanuk Pharma (India) Limited is U74899DL1995PLC065899.

Where is Tanuk Pharma (India) Limited headquartered?

Tanuk Pharma (India) Limited is headquartered at A-11 Kailash Apartments Lala Lajpatrai Marg, New Delhi, Delhi, 110048.

When was Tanuk Pharma (India) Limited incorporated?

Tanuk Pharma (India) Limited was incorporated on 28 February 1995.

Who are the current directors of Tanuk Pharma (India) Limited?

The current directors of Tanuk Pharma (India) Limited are

What is the primary industry of Tanuk Pharma (India) Limited?

The primary industry of Tanuk Pharma (India) Limited is Pharma.

Is Tanuk Pharma (India) Limited a listed company?

Tanuk Pharma (India) Limited is unlisted.

What is the capital structure of Tanuk Pharma (India) Limited?

The authorized capital of Tanuk Pharma (India) Limited is ₹8.50 Cr, and the paid-up capital is ₹3.67 Cr.

What is the compliance status of Tanuk Pharma (India) Limited?

The compliance status of Tanuk Pharma (India) Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available